MedPath

GATT Technologies BV

GATT Technologies BV logo
🇳🇱Netherlands
Ownership
Holding, Subsidiary
Established
2011-01-01
Employees
1
Market Cap
-
Website
http://www.gatt-tech.com

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Not Applicable
Recruiting
Conditions
Gallbladder Diseases
Hemorrhage, Surgical
Intraoperative Bleeding
Liver Diseases
Interventions
Device: GATT-Patch
Device: SURGICEL® Original
First Posted Date
2023-06-12
Last Posted Date
2025-03-12
Lead Sponsor
GATT Technologies BV
Target Recruit Count
50
Registration Number
NCT05900037
Locations
🇺🇸

Capital Health, Pennington, New Jersey, United States

🇺🇸

Washington University, Saint Louis, Missouri, United States

🇺🇸

Atrium Health, Charlotte, North Carolina, United States

and more 3 locations

GATT-Patch Versus TachoSil in Liver Surgery

Not Applicable
Completed
Conditions
Hemorrhage, Surgical
Liver Diseases
Intraoperative Bleeding
Interventions
Device: GATT-Patch
First Posted Date
2022-05-23
Last Posted Date
2025-03-14
Lead Sponsor
GATT Technologies BV
Target Recruit Count
131
Registration Number
NCT05385952
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

Washington University, Saint Louis, Missouri, United States

🇺🇸

Atrium Health, Charlotte, North Carolina, United States

and more 7 locations

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

Not Applicable
Completed
Conditions
Hemorrhage, Surgical
Interventions
Device: GATT-Patch
First Posted Date
2021-03-29
Last Posted Date
2022-05-02
Lead Sponsor
GATT Technologies BV
Target Recruit Count
47
Registration Number
NCT04819945
Locations
🇳🇱

Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

🇳🇱

Erasmus University Medical Center, Rotterdam, Zuid-Holland, Netherlands

🇳🇱

University Medical Center Groningen, Groningen, Netherlands

© Copyright 2025. All Rights Reserved by MedPath